The Consistency Between the Chinese Essential Medicines List and Treatment Guidelines—Taking Oncology Medicines as an Example

Frontiers in Public Health

article

Luyan Cheng¹  Caiyun Li¹  Xuefang Zhang¹  Yongfa Chen¹  Jianzhou Yan¹ 

[1] School of International Pharmaceutical Business, China Pharmaceutical University;The Research Center of National Drug Policy and Ecosystem, China Pharmaceutical University

关键词: essential medicines list;    treatment guidelines;    consistency;    matching degree;    oncology medicine;   

DOI  :  10.3389/fpubh.2022.943994

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

The concepts of “essential medicine” and “national medicine policy” were first put forward for the first time at the World Health Assembly in 1975 in an effort to alleviate the problem of medicine unavailability in developing and poor countries. The essential medicine system in China has experienced three development stages since 1979, when the concept of essential medicines was first introduced, to actively respond to the call of the World Health Organization. Currently, the essential medicines list published in China is the national essential medicines list (2018 Edition). In this study, we examined the consistency between the essential medicines for treating seven cancers (liver cancer, breast cancer, esophageal cancer, lung cancer, colorectal cancer, gastric cancer, and leukemia) and the recommended medicines by cancer treatment guidelines to determine whether the essential medicines are of high quality for clinical needs. The results indicated that the degree of similarity between oncology medicines on the essential medicines list and oncology medicines recommended by guidelines was low, with the majority falling between 30 and 60%. Therefore, to improve the quality of essential medicines, it is necessary to further improve the matching degree. In addition, to further improve the consistency between the essential medicines list and treatment guidelines, the following suggestions are put forward in this paper: (1). Formulate universal treatment guidelines; (2). When selecting essential medicines, greater consideration should be given to those recommended in the guidelines; (3). The essential medicines list and treatment guidelines should be concurrently updated; (4). The cycle for updating the essential medicines list and treatment guidelines should be shortened.

【 授权许可】

CC BY